Overview of current pharmacotherapeutic options in benign prostatic hyperplasia.
Koudonas A, Anastasiadis A, Tsiakaras S, Langas G, Savvides E, Mykoniatis I, Memmos D, Baniotis P, Vakalopoulos I, de la Rosette J, Dimitriadis G.
Koudonas A, et al. Among authors: anastasiadis a.
Expert Opin Pharmacother. 2023 Sep-Dec;24(14):1609-1622. doi: 10.1080/14656566.2023.2237406. Epub 2023 Jul 21.
Expert Opin Pharmacother. 2023.
PMID: 37448198
Review.